The MYOVIEW

Paper Summary:

Amersham Health has developed a product for the next technological advance in cardiac diagnostic testing, MYOVIEW with Rapid Clearance, for myocardial perfusion imaging. This paper explains how the product works and examines how MYOVIEW will help the medical industry and cardiac patients.

From the Paper:

"Myocardial perfusion imaging is the answer to the challenges felt by many physicians when patients may have a suspected myocardial infarction. Oftentimes a physician may feel that a patient is not having an MI, however, as a precautionary measure, will have the patient admitted for observation. If it turns out that they were not having an MI, the patient has now spent unneeded time at the hospital, taking up valuable bed space and staff time, at often over crowded hospitals, that could have been better used by patients who truly needed it. In fact, Udelson states that "missed MI is one of the most common causes of litigation against ED personnel, and this test may also facilitate an earlier diagnosis in such patients(Glow; Udelson, 2003).""

More papers on The MYOVIEW:

• Analytical Essay # 5879 : "John Kenneth Galbraith's 'The Great Crash: 1929'"
• Analytical Essay # 3935 : "James Baldwin's "The Fire Next Time."
• Analytical Essay # 4992 : "Richard Price's Existentialist "The Ladies' Man"

APA Citation:

MLA Citation: